THERAVANCE INC's ticker is THRX and the CUSIP is 88338T104. A total of 1 filers reported holding THERAVANCE INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2013 | $1,793,000 | – | 46,517 | – | 0.36% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baupost Group | 20,395,056 | $607,365,000 | 9.89% |
| Realm Partners LLC | 301,521 | $8,979,000 | 3.75% |
| CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD | 2,805,837 | $83,558,000 | 2.52% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 7,447,743 | $221,794,000 | 2.27% |
| SECTORAL ASSET MANAGEMENT INC | 1,743,188 | $51,912,000 | 2.20% |
| Foundation Asset Management, LP | 255,790 | $7,617,000 | 2.19% |
| Proxima Capital Management, LLC | 550,000 | $16,379,000 | 1.93% |
| Roundview Capital LLC | 140,645 | $4,188,000 | 1.69% |
| BB BIOTECH AG | 933,244 | $27,792,000 | 1.32% |
| PERRY CAPITAL | 1,517,208 | $45,182,000 | 1.25% |